TABLE 1.
Baseline characteristics of participants (n=13)
| Clinical variables | |
|---|---|
| Age, years | 67.4±6.6 |
| Body mass index, kg/m2 | 28.1±3.2 |
| Waist circumference, cm | 99.4±9.3 |
| Canadian Cardiovascular Society functional class, n (%) | |
| 0 | 5 (38) |
| I | 4 (31) |
| II | 4 (31) |
| III or IV | 0 (0) |
| Risk factors, n (%) | |
| Diabetes mellitus | 2 (15) |
| Hypertension | 5 (38) |
| Dyslipidemia | 12 (92) |
| Smoking | 1 (8) |
| Positive family history | 8 (61) |
| Medical history, n (%) | |
| Previous myocardial infarction | 7 (54) |
| PCI | 3 (23) |
| CABG | 3 (23) |
| Medications, n (%) | |
| Acetylsalicylic acid | 12 (92) |
| Beta-blockers | 9 (69) |
| Calcium channel blockers | 5 (38) |
| ACE inhibitors | 2 (15) |
| Statins | 12 (92) |
| Nitrates | 3 (23) |
Data presented as mean ± SD unless otherwise indicated. ACE Angiotensin-converting enzyme; CABG Coronary artery bypass grafting; PCI Percutaneous coronary intervention